BridgeBio Oncology Therapeutics (BBOT) Interest Expenses (2024 - 2026)

BridgeBio Oncology Therapeutics (BBOT) posted Interest Expenses of $15.9 million for Q1 2026, down 62.81% sequentially from $42.8 million in Q4 2025.

BridgeBio Oncology Therapeutics (BBOT) Interest Expenses (2024 - 2026) Analysis & Trends

BridgeBio Oncology Therapeutics has reported Interest Expenses for 3 years, with the latest figure at $15.9 million in Q1 2026.

Quarterly Interest Expenses changed N/A year-over-year to $15.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.9 million (changed N/A YoY) and the FY2025 annual result came in at $87.2 million, up 92.97% from the prior year.
Interest Expenses fell to $15.9 million in Q1 2026 per BBOT's latest filing, from $42.8 million in the prior quarter.
Over five years, Interest Expenses peaked at $45.2 million in Q4 2024 and troughed at $15.9 million in Q1 2026.
A 3-year average of $34.9 million and a median of $39.3 million in 2025 frame the typical range for Interest Expenses.
The widest YoY moves for Interest Expenses: up 5.33% in 2025, down 5.33% in 2025.
Over 3 years, Interest Expenses stood at $45.2 million in 2024, then fell by 5.33% to $42.8 million in 2025, then tumbled by 62.81% to $15.9 million in 2026.
According to Business Quant data, Interest Expenses over the past three periods registered $15.9 million, $42.8 million, and $35.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	439.40 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	52.50 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.70 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	39.74 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	335,572.77
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	218.10 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	82.05 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	20.27 Mn
10	BridgeBio Oncology Therapeutics	726.38 Mn	500.67 Mn	-	10.62 Mn

Download Data